US Stock MarketDetailed Quotes
CYTK Cytokinetics
- 54.090
- -1.840-3.29%
Close Sep 6 16:00 ET
- 54.090
- 0.0000.00%
Post 16:06 ET
6.36BMarket Cap-10091P/E (TTM)
56.360High53.205Low1.40MVolume56.190Open55.930Pre Close75.92MTurnover1.19%Turnover RatioLossP/E (Static)117.66MShares110.25052wk High58.60P/B6.33BFloat Cap25.98052wk Low--Dividend TTM117.05MShs Float110.250Historical High--Div YieldTTM5.64%Amplitude3.050Historical Low54.368Avg Price1Lot Size
Cytokinetics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 18.47%-99.31M | -5.91%-129.51M | -38.33%-414.33M | 24.60%-74.04M | -14.48%-96.21M | -34.63%-121.81M | -356.10%-122.29M | -110.15%-299.52M | -119.48%-98.19M | -116.77%-84.04M |
| Net income from continuing operations | -11.41%-143.32M | -3.32%-135.64M | -35.30%-526.24M | 0.35%-136.9M | 9.06%-129.42M | -549.03%-128.64M | -46.78%-131.29M | -80.65%-388.96M | -349.39%-137.38M | -87.04%-142.31M |
| Operating gains losses | ---- | ---- | -98.75%35K | --0 | --0 | --1K | -98.74%34K | --2.8M | --0 | --107K |
| Depreciation and amortization | 29.70%2.41M | 26.14%2.33M | 104.54%11.89M | 282.09%6.34M | 31.68%1.85M | 31.84%1.86M | 37.81%1.85M | 155.45%5.81M | 125.89%1.66M | 204.76%1.41M |
| Other non cash items | -36.49%6.61M | -28.88%7.89M | -56.95%24.83M | -209.01%-7.84M | -64.94%11.17M | 9.43%10.41M | 21.66%11.1M | 78.10%57.68M | -24.91%7.19M | 274.03%31.85M |
| Change In working capital | 140.53%9.77M | -34.05%-25.7M | 112.50%3.09M | 166.50%44.88M | -87.38%1.48M | 74.30%-24.1M | -147.35%-19.17M | -392.15%-24.7M | 149.48%16.84M | -42.98%11.73M |
| -Change in receivables | 3,871.43%834K | 152.27%449K | -102.00%-1.14M | -43.36%1.22M | -371.65%-1.51M | -99.49%21K | -101.69%-859K | 219.56%56.67M | 104.20%2.15M | -115.61%-321K |
| -Change in prepaid assets | 244.39%8.16M | -307.50%-6.63M | 121.53%1.6M | 458.44%8.53M | 137.62%342K | 14.51%-5.65M | -14.42%-1.63M | -0.45%-7.41M | -60.45%1.53M | 83.95%-909K |
| -Change in payables and accrued expense | 115.00%2.36M | -0.08%-15.87M | -11.37%13.62M | 213.77%39.84M | -55.25%5.39M | -468.35%-15.75M | -140.25%-15.86M | -4.64%15.37M | 149.16%12.7M | 16.20%12.04M |
| -Change in other current liabilities | 41.52%-1.59M | -342.06%-3.65M | -371.72%-10.99M | -1,106.41%-4.71M | -398.47%-2.74M | -85.22%-2.72M | 63.28%-825K | -104.94%-2.33M | -94.28%468K | -93.36%917K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---87M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 18.47%-99.31M | -5.91%-129.51M | -38.33%-414.33M | 24.60%-74.04M | -14.48%-96.21M | -34.63%-121.81M | -356.10%-122.29M | -110.15%-299.52M | -119.48%-98.19M | -116.77%-84.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -893.33%-651.55M | -80.28%32.64M | 191.27%239.25M | -378.34%-81.41M | 124.98%73.04M | 25.83%82.13M | 357.47%165.5M | -77.38%-262.13M | -38.21%29.25M | -40.08%-292.37M |
| Net PPE purchase and sale | -167.09%-1.92M | --0 | 87.51%-1.42M | 97.60%-77K | 96.53%-220K | 16.34%-717K | 57.32%-402K | 76.81%-11.34M | 81.95%-3.21M | 59.68%-6.33M |
| Net investment purchase and sale | -884.15%-649.63M | -80.32%32.64M | 195.96%240.67M | -350.61%-81.33M | 125.61%73.26M | 25.29%82.85M | 361.93%165.9M | -153.58%-250.8M | -50.14%32.45M | -48.19%-286.04M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -893.33%-651.55M | -80.28%32.64M | 191.27%239.25M | -378.34%-81.41M | 124.98%73.04M | 25.83%82.13M | 357.47%165.5M | -77.38%-262.13M | -38.21%29.25M | -40.08%-292.37M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 14,895.63%821.01M | 1,546.16%103.79M | -57.12%221.32M | 464.83%168.8M | -86.06%54.22M | 60.28%5.48M | -107.65%-7.18M | 61.31%516.17M | 53.21%29.89M | 29.29%389.02M |
| Net issuance payments of debt | -1,257.55%-2.88M | -350.24%-932K | -100.26%-858K | -111.43%-222K | -100.06%-217K | 20.60%-212K | 99.57%-207K | --334.66M | ---105K | --382.83M |
| Net common stock issuance | --613.2M | --93.64M | --164.23M | --162.92M | --1.31M | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | 87.88%10.69M | 732.59%29.53M | 5.22%18.46M | 69.57%6.1M | -49.51%3.12M | 54.41%5.69M | -12.96%3.55M | 41.70%17.54M | -59.16%3.6M | 55.06%6.19M |
| Net other financing activities | --200M | -75.42%-18.45M | -75.92%39.48M | --0 | --50M | --0 | -107.64%-10.52M | 3,785.37%163.96M | --26.39M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 14,895.63%821.01M | 1,546.16%103.79M | -57.12%221.32M | 464.83%168.8M | -86.06%54.22M | 60.28%5.48M | -107.65%-7.18M | 61.31%516.17M | 53.21%29.89M | 29.29%389.02M |
| Net cash flow | ||||||||||
| Beginning cash position | 16.60%120.35M | 68.79%113.4M | -40.37%67.18M | -5.81%100.07M | -26.29%69.01M | -10.58%103.22M | -40.37%67.18M | 35.77%112.67M | 17.31%106.24M | 152.01%93.63M |
| Current changes in cash | 305.10%70.15M | -80.78%6.93M | 201.66%46.24M | 134.19%13.35M | 146.32%31.05M | -56.95%-34.2M | 1,207.47%36.03M | -253.24%-45.48M | -276.69%-39.06M | -76.39%12.61M |
| Effect of exchange rate changes | --16K | --27K | ---20K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| End cash Position | 176.06%190.52M | 16.60%120.35M | 68.79%113.4M | 68.79%113.4M | -5.81%100.07M | -26.29%69.01M | -10.58%103.22M | -40.37%67.18M | -40.37%67.18M | 17.31%106.24M |
| Free cash flow | 17.38%-101.23M | -5.56%-129.51M | -33.75%-415.75M | 26.91%-74.11M | -6.70%-96.43M | -34.15%-122.52M | -342.07%-122.69M | -62.41%-310.85M | -62.26%-101.4M | -65.91%-90.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg